Fidelity SPDR Advertisement
Home > Boards > Stock Clubs > Technical Analysis > PriceTeam

$SPX charts:

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
PriceTeam Member Profile
 
Followed By 19
Posts 968
Boards Moderated 1
Alias Born 05/01/09
160x600 placeholder
Roche Hit By Failure Of Cancer Drug Trial
Roche said a late-stage study of its breast cancer drug Kadcyla failed to yield superior results to an existing treatment, damaging the outlook for stronger sales in one of its key drug markets.
More Top Equities Stories Of The Day
Deezer Names New CEO Before Full U.S. Launch
Whistleblowers Score a Big Payday -- Update
Mobile's Rise Poses a Riddle for Banks
AT&T Boosts Dividend
U.S. Hot Stocks: Hot Stocks to Watch
Brazilian Shares Rise, Led by Rossi Residencial; Real Weakens Slightly
Oracle Beats Street View for First Time in a Year
Alstom CEO Expects to Settle DOJ Bribery Allegations Very Soon
PriceTeam   Friday, 05/08/09 06:57:02 PM
Re: None
Post # of 183 
$SPX charts:

While absolutely anything could happen, this chart wants to tap SPX 940 and perhaps even 950 before retreating into Options Expiration on 5/15.





Strip price to the barest data that tells us BUY, HOLD, or SELL.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist